secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sorrento Therapeutics, Inc. (—)
CIK:        0000850261
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001104659-23-019893
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sorrento Therapeutics receives Nasdaq delisting notice after Chapter 11 filing; stock to move to Pink Market on Feb 23
--------------------------------------------------------------------------------

- Sorrento Therapeutics and subsidiary Scintilla Pharmaceuticals filed for Chapter 11 on Feb 13, 2023, in Southern District of Texas.
- Nasdaq notified Sorrento of delisting due to Chapter 11 filing and public concerns; company will not appeal; trading suspended Feb 23.
- Common stock expected to trade on Pink Open Market beginning Feb 23; no assurance of continued trading.
- Company cautions trading prices may bear little relation to actual recovery for holders in Chapter 11 proceedings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/850261/000110465923019893/0001104659-23-019893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/850261/000110465923019893/tm236665d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-019893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer